B

BSX

Boston Scientific Corporation
HealthcareMedical - Devices|New York Stock Exchange|US

Price

$62.82

Market Cap

$93.22B

Beta

0.78

P/E

32.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+19.88%
EPS Growth (YoY)+54.82%
Revenue CAGR 3Y+16.54%
P/E Ratio32.0
PEG Ratio0.59
FCF Yield+3.89%
Debt / Equity0.51
Interest Coverage11.2x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for BSX.

BSX — Boston Scientific Corporation Stock Analysis | Tessera Alpha